ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

139 hedge funds and large institutions have $1.5B invested in Alnylam Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 139 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
139
Holders Change
+139
Holders Change %
–
% of All Funds
4.54%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
139
Increased
–
Reduced
–
Closed
–
Calls
$14.4M
Puts
$7.2M
Net Calls
+$7.25M
Net Calls Change
+$7.25M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
126
Royal Bank of Canada
Ontario, Canada
$109K 3,525 +3,525 New
GT
127
Glenmede Trust
Pennsylvania
$103K 3,350 +3,350 New
Group One Trading
128
Group One Trading
Illinois
$102K 3,274 +3,274 New
MA
129
MUFG Americas
New York
$99K 3,200 +3,200 New
HNB
130
Huntington National Bank
Ohio
$93K 3,000 +3,000 New
ILIM
131
Irish Life Investment Managers
Ireland
$85.4K 2,760 +2,760 New
US Bancorp
132
US Bancorp
Minnesota
$62K 2,000 +2,000 New
LTFS
133
Ladenburg Thalmann Financial Services
Florida
$40K 1,300 +1,300 New
BPBT
134
Boston Private Bank & Trust
Massachusetts
$34K 1,100 +1,100 New
OMCS
135
Old Mutual Customised Solutions
South Africa
$31K 1,000 +1,000 New
TRCT
136
Tower Research Capital (TRC)
New York
$23K 729 +729 New
Federated Hermes
137
Federated Hermes
Pennsylvania
$17K 562 +562 New
Bank of Montreal
138
Bank of Montreal
Ontario, Canada
$6K 189 +189 New
SSG
139
Summit Securities Group
New York
$3K 100 +100 New
Millennium Management
140
Millennium Management
New York
– – – –
Susquehanna International Group
141
Susquehanna International Group
Pennsylvania
– – – –
SM
142
Sabby Management
Florida
– – – –
TH
143
Timber Hill
Connecticut
– – – –
PG
144
PEAK6 Group
Illinois
– – – –
GACM
145
Green Arrow Capital Management
New York
– – – –
2 3 4 5
6